Patenton — panteon of patents

(19)

RU

(11)

2 500 815

(13)

C2

(51)

IPC

C12N15/11(2006-01-01)

A61K31/7105(2006-01-01)

A61K39/00(2006-01-01)

A61P35/00(2006-01-01)

(21) (22)

Application

2009107153/10, 2007-07-25

(24)

Start date

2007-07-25

(22)

Actual filing date

2007-07-25

(45)

Published

2013-12-10

(72)

Inventor

Ogast PolKhuan Vaan TszenNatesan ShridaranLiberman Sojan

(73)

Holder

Sanofi-Aventis

COMPOSITION AND METHOD OF TUMOUR CURING Russian patent published in 2013 - IPC C12N15/11 A61K31/7105 A61K39/00 A61P35/00 

Abstract RU 2500815 C2

FIELD: biotechnologies.

SUBSTANCE: following components are obtained: composition including inhibitor of TNF-suppressing activity Core 1 of mitochondrial breathing assembly III in a tumour cell based on nucleic acid; a member of superfamily of tumour necrosis factor (TNF); and a carrier.

EFFECT: invention allows increasing sensitivity of a tumour cell to apoptotic activity of a member of superfamily of tumour necrosis factor.

16 cl, 5 dwg, 9 ex

Similar patents RU2500815C2

Title Year Author Number
APOPTOTIC Apo2L/TRAIL SENSITIVITY BY TESTING GalNac-T14 EXPRESSION IN CELLS/TISSUES 2006
  • Vagner Klaus V.
  • Ashkenazi Avi Dzh.
 RU2416097C2
COMBINATION OF ANTIBODY HAVING SELECTIVITY IN RELATES TO APOPTOSIS INDUCING LIGAND RECEPTOR ASSOCIATED WITH TUMOR NECROSIS FACTOR AND OTHER THERAPEUTIC AGENTS 2002
  • Chzhou Tun
  • Itikava Kimikhisa
  • Kimberli Robert P.
  • Kupman Uil'Jam Dzh.
  • Osumi Dzhun
  • Lobuglio Al'Bert F.
  • Bukhsbaum Donal'D Dzh.
 RU2313368C2
ANTIBODY SELECTIVE TO RECEPTOR APOPTOSIS-INDUCING LIGAND AND ASSOCIATED WITH TUMOR NECROSIS FACTOR AND ITS USING 2002
  • Chzhou Tun
  • Kimberli Robert P.
  • Kupman Uil'Jam Dzh.
  • Lobuglio Al'Bert F.
  • Bukhsbaum Donal'D Dzh.
 RU2313537C2
ANALYSES AND METHODS OF BIOMARKER APPLICATION 2006
  • Vagner Klaus V.
  • Ashkenazi Avi Dzh.
 RU2409817C2
APOPTOSIS DETECTION TECHNIQUES AND REAGENTS 2007
  • Ostin Kehri D.
  • Lorens Dehvid A.
  • Ashkenazi Avi
 RU2450273C2
ANTIBODY SELECTIVE TO APOPTOSIS INDUCING LIGAND RECEPTOR ASSOCIATED WITH TUMOR NECROSIS FACTOR, AND USES THEREOF 2001
  • Zou Tong
  • Itikava Kimikhisa
  • Kimberli Robert P.
  • Kupman Uill'Jam Dzh.
 RU2298013C2
METHODS OF APPLYING OF APO-2L-RECEPTORS AGONISTS AND NK-CELLS ACTIVATORS 2005
  • Godovski Pol Dzh.
  • Satial Sandzhiv Kh.
 RU2395294C2
METHODS AND COMPOSITIONS FOR INDUCING APOPTOSIS OF CANCER CELLS 2003
  • Mark Nasoff
  • Kvinn L. Deveroks
  • Debora A. Kni
  • Pedro Asa-Blank
  • Garret M. Khehmpton
  • Klaus Vagner
 RU2379056C2
ANALYSES AND METHODS WITH APPLICATION OF BIOMARKERS 2005
  • Vagner Klaus V.
 RU2431676C2
METHODS OF TREATING CANCER, HAVING HEMIZYGOUS LOSS OF TP53 2016
  • Liu, Yunhua
  • Lu, Xiongbin
 RU2721953C2

RU 2 500 815 C2

Authors

Ogast Pol

Khuan Vaan Tszen

Natesan Shridaran

Liberman Sojan

Dates

2013-12-10—Published

2007-07-25—Filed

download Download PDF read Similar patents